Institutional investors hold a majority ownership of GILD through the 88.50% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 1.0 Million shares of Gilead Sciences
STRATEGIC ADVISERS, INC. Bought 769.4 Thousand shares of Gilead Sciences
CANDRIAM BELGIUM SA Bought 691.2 Thousand shares of Gilead Sciences